Literature DB >> 11038208

Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma.

A Miyauchi1, F Matsuzuka, K Hirai, T Yokozawa, K Kobayashi, S Kuma, K Kuma, H Futami, K Yamaguchi.   

Abstract

Compared to hereditary medullary thyroid carcinoma (MTC), sporadic MTC tends to be unicentric and confined to one lobe. Patients with sporadic MTC usually undergo total thyroidectomy because of a possible hereditary or bilateral process. We evaluated the usefulness of germline RET oncogene mutation analysis in surgery for apparently sporadic MTC and performed unilateral surgery on patients without detectable mutation. In 36 patients with a preoperative diagnosis of apparently sporadic MTC, we performed germline RET oncogene mutation analyses: before surgery in 8 recent patients and after surgery in 28 who had been treated before 1996. Of the latter, 5 had bilateral MTC. DNA samples were extracted from their peripheral blood, and the polymerase chain reaction products of the RET proto-oncogene were analyzed using single-strand conformation polymorphism analysis and the direct sequencing methods. Before 1996 we often performed total thyroidectomy but changed to hemithyroidectomy thereafter, except in one patient with associated Graves' ophthalmopathy. Our minimal standard practice included systematic central and ipsilateral neck dissection. The outcome was assessed in terms of gastrin- and calcium-stimulated plasma calcitonin levels. Germline RET mutations were found in six patients. Five of these patients had bilateral MTC, whereas all 30 patients without mutation had unilateral disease. Hemithyroidectomy in seven of our recent patients resulted in normalization of plasma calcitonin levels in all, although four were found to have microscopic lymph node involvement. In conclusion, hemithyroidectomy with systematic central and ipsilateral neck dissection is an appropriate procedure for patients with sporadic MTC without detectable germline RET mutations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11038208     DOI: 10.1007/s002680010226

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  9 in total

Review 1.  Medullary thyroid carcinoma--update and present management controversies.

Authors:  Mahir Al-Rawi; Malcolm H Wheeler
Journal:  Ann R Coll Surg Engl       Date:  2006-09       Impact factor: 1.891

2.  [Surgery of thyroid carcinoma].

Authors:  H Dralle; K Lorenz; A Machens
Journal:  Chirurg       Date:  2009-11       Impact factor: 0.955

3.  Incidentally found medullary thyroid cancer: treatment rationale for small tumors.

Authors:  Andreas Raffel; Kenko Cupisti; Markus Krausch; Achim Wolf; Klaus-Martin Schulte; Hans-Dietrich Röher
Journal:  World J Surg       Date:  2004-03-04       Impact factor: 3.352

4.  Excellent prognosis of patients with nonhereditary medullary thyroid carcinoma with ultrasonographic findings of follicular tumor or benign nodule.

Authors:  Mitsuhiro Fukushima; Yasuhiro Ito; Mitsuyoshi Hirokawa; Akihiro Miya; Kaoru Kobayashi; Haruki Akasu; Kazuo Shimizu; Akira Miyauchi
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

5.  Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution.

Authors:  Yasuhiro Ito; Akira Miyauchi; Tomonori Yabuta; Mitsuhiro Fukushima; Hiroyuki Inoue; Chisato Tomoda; Takashi Uruno; Minoru Kihara; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

6.  Multifocality in Sporadic Medullary Thyroid Carcinoma: An International Multicenter Study.

Authors:  Garth F Essig; Kyle Porter; David Schneider; Debora Arpaia; Susan C Lindsey; Giulia Busonero; Daniel Fineberg; Barbara Fruci; Kristien Boelaert; Johannes W Smit; Johannes Arnoldus Anthonius Meijer; Leonidas H Duntas; Neil Sharma; Giuseppe Costante; Sebastiano Filetti; Rebecca S Sippel; Bernadette Biondi; Duncan J Topliss; Furio Pacini; Rui M B Maciel; Patrick C Walz; Richard T Kloos
Journal:  Thyroid       Date:  2016-10-11       Impact factor: 6.568

7.  Static Prognostic Factors and Appropriate Surgical Designs for Patients with Medullary Thyroid Carcinoma: The Second Report from a Single-Institution Study in Japan.

Authors:  Yasuhiro Ito; Akira Miyauchi; Minoru Kihara; Takuya Higashiiyama; Mitsuhiro Fukushima; Akihiro Miya
Journal:  World J Surg       Date:  2018-12       Impact factor: 3.352

Review 8.  Update on the Diagnosis and Management of Medullary Thyroid Cancer: What Has Changed in Recent Years?

Authors:  Krzysztof Kaliszewski; Maksymilian Ludwig; Bartłomiej Ludwig; Agnieszka Mikuła; Maria Greniuk; Jerzy Rudnicki
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

9.  Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines.

Authors:  Daqi Zhang; Carla Colombo; Hui Sun; Hoon Yub Kim; Antonella Pino; Simone De Leo; Giacomo Gazzano; Luca Persani; Gianlorenzo Dionigi; Laura Fugazzola
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-11       Impact factor: 6.055

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.